CoChat
Sign Up
Cited by 13

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Association between PARK16 and Parkinson’s disease: A meta-analysis

He, Tao, Wang, Jie, Wang, Xiaoli, Deng, Wenshuai, Jiang, Hong, Xie, Junxia, Sun, Peng·2017·Neuroscience Letters
DOI 10.1016/j.neulet.2017.08.022
Open this paper in CoChat — free account

Abstract

Recent years, several case-control studies reported that two polymorphisms (rs947211 and 1572913) within the PARK16 locus were associated with the Parkinson's disease (PD). However, the results were still controversial. Herein, we conducted a comprehensive meta-analysis to estimate the associations between two polymorphisms and PD. Seven databases (PubMed, Google Scholar, EMBASE, Web of Science, CNKI (China National Knowledge Infrastructure), VIP and Wanfang) were searched to identify the eligible studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the associations of two polymorphisms with PD susceptibility. Totally, 15 studies with 6637 cases and 6774 controls were included in our meta-analysis. The results showed that rs947211 variants were associated with a decreased risk of PD in overall population. Stratified analysis found that rs947211 variants were associated with a significantly decreased risk of PD in Northeast Asian population, but a slightly decreased risk of PD in Southeast Asian and Caucasian population. With regard to rs1572913 polymorphism, the results suggested that rs1572913 variants contribute to decrease the risk of PD. Therefore, our meta-analysis suggested that rs947211 variants (A allele, AG and GG genotypes) may decrease the risk of PD in overall population, particularly in Northeast Asian population; and T allele, TC and TT genotypes of rs1572913 variants contributed to decrease the risk of PD.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neulet.2017.08.022

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. Lang, 1998, Parkinson's disease. First of two parts, N. Engl. J. Med., 339, 1044, 10.1056/NEJM199810083391506 · DOI
  2. Emamalizadeh, 2014, RIT2, a susceptibility gene for Parkinson's disease in Iranian population, Neurobiol. Aging, 35, e27, 10.1016/j.neurobiolaging.2014.07.013 · DOI
  3. Satake, 2009, Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease, Nat. Genet., 41, 1303, 10.1038/ng.485 · DOI
  4. Hamza, 2010, Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease, Nat. Genet., 42, 781, 10.1038/ng.642 · DOI
  5. Spencer, 2011, Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21, Hum. Mol. Genet., 20, 345, 10.1093/hmg/ddq469 · DOI
  6. Chang, 2013, Association between PARK16 and Parkinson's disease in the Han Chinese population: a meta-analysis, Neurobiol. Aging, 34, 2442, 10.1016/j.neurobiolaging.2013.04.028 · DOI
  7. Yan, 2011, An association between the PARK16 locus and Parkinson's disease in a cohort from eastern China, Parkinsonism Relat. Disord., 17, 737, 10.1016/j.parkreldis.2011.07.012 · DOI
  8. Tan, 2010, Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus, Neurology, 75, 508, 10.1212/WNL.0b013e3181eccfcd · DOI
  9. Gopalai, 2016, PARK16 is associated with PD in the Malaysian population, Am. J. Med. Genet. B Neuropsychiatr. Genet., 171, 839, 10.1002/ajmg.b.32454 · DOI
  10. Miyake, 2016, PARK16 polymorphisms, interaction with smoking, and sporadic Parkinson's disease in Japan, J. Neurol. Sci., 362, 47, 10.1016/j.jns.2016.01.021 · DOI
  11. Xia, 2015, Association between PARK16 gene polymorphisms and susceptibility of Parkinson's disease in a Chinese population, Genet. Mol. Res., 14, 2978, 10.4238/2015.April.10.7 · DOI
  12. Zhou, 2014, Association analysis of PARK16-18 variants and Parkinson's disease in a Chinese population, J. Clin. Neurosci., 21, 1029, 10.1016/j.jocn.2013.09.015 · DOI
  13. Li, 2011, Association of PARK 16 polymorphisms with Parkinson's disease in Han population of Suzhou area, Zhonghua Yi Xue Za Zhi, 91, 296
  14. ZhaoYY, 2011, Association between polymorphisms of PARK16 gene and susceptibility to Parkinson's disease in Chinese Han population, Chin. J. Neurol., 44, 343
  15. Gan-Or, 2012, Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk, Arch. Neurol., 69, 105, 10.1001/archneurol.2011.924 · DOI · Paper page
  16. Ramirez, 2011, Association of Parkinson disease to PARK16 in a Chilean sample, Parkinsonism Relat. Disord., 17, 70, 10.1016/j.parkreldis.2010.09.002 · DOI
  17. Long, 2016, Study on PARK α-synuclein gene mutation and polymorphism of minority patients with Parkinson's disease, Chin. J. Endem. Dis., 31, 22
  18. Chung, 2013, Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population, Neurobiol. Aging, 34, 2695, 10.1016/j.neurobiolaging.2013.05.022 · DOI
  19. Guo, 2014, An association analysis of the rs1572931 polymorphism of the RAB7L1 gene in Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in China, Eur. J. Neurol., 21, 1337, 10.1111/ene.12490 · DOI · Paper page
  20. Goudarzian, 2015, The rs1572931 polymorphism of the RAB7L1 gene promoter is associated with reduced risk of Parkinson's disease, Neurol. Res., 37, 1029, 10.1179/1743132815Y.0000000085 · DOI · Paper page
  21. Liu, 2016, Association between RAB7L1 gene promoter polymorphism and Parkinson disease in Southwestern Chinese Han Population.Nervous, Dise. Mental Health, 16, 297
  22. Woolf, 1955, On estimating the relation between blood group and disease, Ann. Hum. Genet., 19, 251, 10.1111/j.1469-1809.1955.tb01348.x · DOI
  23. Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat. Med., 21, 1539, 10.1002/sim.1186 · DOI · Paper page
  24. Zintzaras, 2005, Heterogeneity testing in meta-analysis of genome searches, Genet. Epidemiol., 28, 123, 10.1002/gepi.20048 · DOI
  25. Lau, 1997, Quantitative synthesis in systematic reviews, Ann. Intern. Med., 127, 820, 10.7326/0003-4819-127-9-199711010-00008 · DOI · Paper page
  26. Martin, 1959, Statistical aspects of poliomyelitis in England and Wales in recent years, Mon. Bull. Minist. Health Public Health Lab. Serv., 18, 54
  27. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  28. de Rijk, 2000, Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology, 54, S21, 10.1212/WNL.54.5.21A · DOI
  29. Ostvold, 2001, Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo, Eur. J. Biochem., 268, 2430, 10.1046/j.1432-1327.2001.02120.x · DOI
  30. Zhang, 2007, Genetic studies of human diversity in East Asia, Philos. Trans. R Soc. Lond. B Biol. Sci., 362, 987, 10.1098/rstb.2007.2028 · DOI
  31. Di, 2014, HLA variation reveals genetic continuity rather than population group structure in East Asia, Immunogenetics, 66, 153, 10.1007/s00251-014-0757-6 · DOI
  32. Su, 1999, Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age, Am. J. Hum. Genet., 65, 1718, 10.1086/302680 · DOI
  33. Shi, 2005, Y-chromosome evidence of southern origin of the East Asian-specific haplogroup O3-M122, Am. J. Hum. Genet., 77, 408, 10.1086/444436 · DOI
  34. Yao, 2000, Gene admixture in the silk road region of China: evidence from mtDNA and melanocortin 1 receptor polymorphism, Genes Genet. Syst., 75, 173, 10.1266/ggs.75.173 · DOI
  35. Shimizu, 1997, Cloning and chromosome assignment to 1q32 of a human cDNA (RAB7L1) encoding a small GTP-binding protein, a member of the RAS superfamily, Cytogenet. Cell Genet., 77, 261, 10.1159/000134591 · DOI
  36. MacLeod, 2013, RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk, Neuron, 77, 425, 10.1016/j.neuron.2012.11.033 · DOI · Paper page
  37. Vilariño-Güell, 2011, VPS35 mutations in Parkinson disease, Am. J. Hum. Genet., 89, 162, 10.1016/j.ajhg.2011.06.001 · DOI · Paper page
  38. Bonifacino, 2008, Retromer, Curr. Opin. Cell Biol., 20, 427, 10.1016/j.ceb.2008.03.009 · DOI · Paper page
  39. Arighi, 2004, Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor, J. Cell Biol., 165, 123, 10.1083/jcb.200312055 · DOI · Paper page
  40. Braschi, 2010, Vps35 mediates vesicle transport between the mitochondria and peroxisomes, Curr. Biol., 20, 1310, 10.1016/j.cub.2010.05.066 · DOI

Cited by

Sorted by citations

Metadata

Authors
He, T., Wang, J., Wang, X., Deng, W., Jiang, H., Xie, J., & Sun, P.
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2017-09
Volume
657
Pages
179-188
ISSN
0304-3940
DOI
10.1016/j.neulet.2017.08.022
Cited by
13
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Natural Science Foundation of China (81671305)
  • key Development Projects of Shandong Province (2015GSF118177)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review